Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients
Abstract
Share and Cite
Gorący, I.; Kaczmarczyk, M.; Ciechanowicz, A.; Lewandowska, K.; Jakubiszyn, P.; Bodnar, O.; Kopijek, B.; Brodkiewicz, A.; Cyryłowski, L. Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients. Medicina 2019, 55, 558. https://doi.org/10.3390/medicina55090558
Gorący I, Kaczmarczyk M, Ciechanowicz A, Lewandowska K, Jakubiszyn P, Bodnar O, Kopijek B, Brodkiewicz A, Cyryłowski L. Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients. Medicina. 2019; 55(9):558. https://doi.org/10.3390/medicina55090558
Chicago/Turabian StyleGorący, Iwona, Mariusz Kaczmarczyk, Andrzej Ciechanowicz, Klaudyna Lewandowska, Paweł Jakubiszyn, Oksana Bodnar, Bartosz Kopijek, Andrzej Brodkiewicz, and Lech Cyryłowski. 2019. "Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients" Medicina 55, no. 9: 558. https://doi.org/10.3390/medicina55090558
APA StyleGorący, I., Kaczmarczyk, M., Ciechanowicz, A., Lewandowska, K., Jakubiszyn, P., Bodnar, O., Kopijek, B., Brodkiewicz, A., & Cyryłowski, L. (2019). Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients. Medicina, 55(9), 558. https://doi.org/10.3390/medicina55090558

